Thanks, Rob. As reported this morning, net income for the third quarter of 2023 was $4.2 million or $0.20 per diluted share compared to a net loss of $6.4 million or $0.30 per diluted share in the third quarter of 2022. Net income for the current and prior year quarters each include a noncash impairment charge related to our investment -- equity investment in Grupo Vasconia of $300,000 and $6.2 million, respectively. Adjusted net income was $7.7 million for the third quarter of '23 or $0.36 per diluted share compared to $6.2 million or $0.29 per diluted share in 2022. Income from operations was $13.6 million in the third quarter of '23 as compared to $7.6 million in the 2022 period. Adjusted income from operations in the third quarter of '23 was $17.7 million compared to $16.8 million in 2022. And adjusted EBITDA for the trailing 12 months ended September 30, '23 was $55.5 million before a pro forma synergy adjustment. Adjusted net income, adjusted income from operations and adjusted EBITDA are non-GAAP financial measures, which are reconciled to our GAAP financial measures in the earnings release. The following comments are for the third quarter of '23 and '22, unless stated otherwise. Consolidated sales increased by 2.7% from 2022. U.S. segment sales increased by 3.8% to $179.4 million. As Rob discussed, our core U.S. business continues to rebound, and retailer purchasing behavior continues to normalize. This factor, as well as a new warehouse program, drove the current quarter increase, with a partial offset from lower sales for hydration products. International segment sales were down 10.9% to $12.3 million or down 16.6% on a constant U.S. dollar basis. The decrease is driven by continuing weakness in end market demand, the timing of customer shipments, and as expected, implementation of the new go-to-market strategy in Asia. Gross margin percent increased from -- to 37% from 36.4%. For the U.S. segment, gross margin increased to 37.3% from 36.6%. This improvement is due to favorable product mix and lower inbound freight costs. For international, gross margin decreased 10 basis points to 32.5% from unfavorable product mix, which offset the benefit of lower inbound freight costs. For the U.S., distribution expenses as a percent of goods shipped from its warehouses, excluding nonrecurring expenses, were 9.1% and 10.4% last year. This decrease was driven by lower storage and talent expense. Direct labor productivity improvements offset higher wage rates. For International distribution expense as a percent of goods shipped from its warehouses was 22.4% versus 22.9% last year. The benefit of lower outbound freight rates was partially offset by the effect of the lower shipments on warehouse operations. Selling, general and administrative expenses increased to $40.2 million in '23 versus $36.5 million. U.S. segment expenses increased by $3.3 million to $31.6 million. And as a percentage of net sales, SG&A increased to 17.6% from 16.4%. The increase was primarily attributable to the timing of incentive compensation accruals. For international, SG&A expense decreased by 5% to $3.7 million from lower foreign currency exchange losses. As a percentage of net sales, International segment expenses increased to 30.1% from 28.3% due to the effect of period expenses on lower sales volume. Unallocated corporate expenses increased by $600,000 to $4.9 million on the timing of incentive compensation accruals, partially offset by a decrease in salary costs due to the elimination of the Executive Chairman position. Our interest expense increased by $600,000 due to higher interest rates on our variable rate debt, but partially offset by lower average borrowings. For income taxes, the effective income tax rate was 36.5% for the current quarter, which differs from the federal statutory income tax rate of 21%, primarily due to foreign operating losses for which no tax benefit is recognized. Related to Grupo Vasconia, a Mexican company for which we have a 24.7% equity interest, the company recorded a loss of $700,000 in the '23 period versus a loss of $2 million last year. Vasconia has a recent history of operating losses and recently announced it will not make its debt service payments. Furthermore, its quoted stock price continues to decline. Accordingly, the company recorded an additional noncash impairment charge of $300,000 to write down the investment to its trading value of $4 million. And our balance sheet continues to be strong. At September 30, our liquidity was approximately $198.8 million, which was comprised of availability under our credit facility and receivable purchase agreement and cash on hand. Net debt was $221.7 million, approximately $11 million lower than at the end of 2022. And the net debt-to-EBITDA leverage ratio was 4.0x. As Rob commented, we are very pleased to report that we have received the required commitments to amend and extend our Term Loan B agreement to August 2027. The principal amount will be $150 million priced at 96 OID and bears interest at SOPA plus 550. The definitive agreement will be filed after closing, which is expected shortly. On a pro forma basis, as of September 30, after giving effect to the amendment, liquidity would be approximately $140 million. As discussed in the release, we have updated our financial guidance, raising the low end of our full year 2023 guidance. Guidance for 2023 is as follows: net sales of $670 million to $690 million, adjusted income from operations of $43.5 million to $46.5 million, adjusted net income of $11.1 million to $12.3 million and adjusted EBITDA of $52 million to $55 million. This concludes our prepared comments. Operator, please open the line for questions.